Discovery of novel structural imidazolylvinylquinolones exerting excellent broad-spectrum antibacterial efficacy with multitargeting potential

Key Points

• Novel imidazolylvinylquinolones exhibit excellent broad-spectrum antibacterial efficacy against various pathogens, highlighting their potential use in treatment.
• The lead compound shows significant antibacterial activity, outperforming conventional antibiotics against resistant strains during laboratory tests.
• Discovery involves complex structural analysis and efficacy testing across multiple bacterial species, confirming multitargeting properties integral to their function.
• Highlights the need for further development and testing in clinical settings to establish safety and effectiveness of these compounds for broad therapeutic use.